NCT00596817View on ClinicalTrials.gov

Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes

PHASE3CompletedINTERVENTIONAL
Enrollment

639

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2009

Study Completion Date

October 31, 2009

Conditions
Major Depressive Disorder
Interventions
DRUG

Placebo

capsules, daily, orally

DRUG

Vortioxetine (Lu AA21004)

encapsulated tablets, daily, orally

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY

NCT00596817 - Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes | Biotech Hunter | Biotech Hunter